Fundz

Fundz Deep Dive

Everything you need to win Tyler Benedum — in one platform.

Who to reach, what to say, and why now on Tyler Benedum — plus every funding round, exec hire, and M&A move that follows, each with the verified contact and the outreach written for you.

Get the full Deep Dive on Tyler Benedum — free.

One free Deep Dive, emailed to you. No spam; unsubscribe anytime.

Ready now? Choose your plan · Request a demo · Sign in

Engage writes the reply
Grounded in signals no one else has — tuned to their persona.
Signals no one else has
UCC liens, benefit plans, 13F holdings, permits, exec moves — fused.
Verified contact + click-to-call
The decision-maker’s email and mobile — dial in-browser.

Aktis Oncology Promotes Tyler Benedum, Ph.D., To Chief Technical Officer

PUBLIC · AKTSMay 30, 2024•about 2 years ago

Position

Chief Technical Officer

Company

Aktis Oncology

Tyler Benedum
BostonBiotechnologyHealth CareTherapeutics

Description

Aktis Oncology announced the promotion of Tyler Benedum, Ph.D., to Chief Technical Officer, effective immediately. With nearly 20 years of pharmaceutical and biotech experience, Dr. Benedum brings significant organizational leadership, strategy, and technical expertise to the role

Company Information

Company

Aktis Oncology

Location

Boston, Massachusetts, United States

About

Aktis Oncology is a biotechnology company pioneering the discovery and development of a new class of targeted radiopharmaceuticals to treat a broad range of solid tumor cancers.

Related People

Suggested for you

Choose your plan to reveal verified contacts

Predictive Intelligence
Strategic

ML-powered predictions for Aktis Oncology's next move

Learn about Strategic plan

Executive Insights

Based on hiring data
New executive impact window
87% of new executives make significant technology decisions within first 100 days
Budget influence
C-level executives control 73% of technology spending decisions
Transformation catalyst
65% of new senior hires launch digital transformation initiatives
Vendor review timeline
New executives typically review existing vendors within 6 months

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals — including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications — based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include FundzWatch™ for automated website change detection, Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 200,000+ companies. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.